Related Experiment Video
Updated: Jun 12, 2026
12:27
A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
Published on: June 8, 2022
Sphingosine 1-phosphate and cancer
1Cell Biology Group, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 27 Taylor Street, Glasgow G4 0NR, UK. n.j.pyne@strath.ac.uk
Nature Reviews. Cancer
|June 18, 2010
Summary
Sphingosine 1-phosphate (S1P) plays a key role in cancer by regulating inflammation, blood vessel growth, and cell survival. Targeting S1P signaling pathways offers potential for novel cancer therapeutics.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Sphingosine 1-phosphate (S1P) is implicated in cancer development and progression.
- S1P influences critical processes including inflammation, neovascularization, and cell growth/survival.
- Multiple molecular components, including S1P receptors and enzymes, mediate S1P's effects.
Purpose of the Study:
- To review current research on S1P's role in cancer.
- To examine the therapeutic potential of targeting S1P signaling in oncology.
Main Methods:
- Literature review of current research findings.
- Analysis of S1P signaling pathways in cancer.
Main Results:
- S1P is a significant regulator of tumorigenesis.
- S1P signaling impacts inflammation, angiogenesis, and cell proliferation/survival.
- Targeting S1P pathways presents therapeutic opportunities.
Conclusions:
- S1P is a crucial mediator in cancer biology.
- Modulating S1P signaling holds promise for developing new anti-cancer drugs.
Related Concept Videos
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
01:42Phosphoinositides and PIPs
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
01:35Cancer Cell Migration through Invadopodia
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...